Delivery Order SPE2DB22D6029-SPE2DB24FU0RJ
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,732.66, is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,484.91, is for the delivery of the medication TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. It is a firm fixed-price delivery order contract with a completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,598.99 contract is for the supply of 620 mcg/2.48 ml teriparatide, a specialty medication, with a completion date of January 26, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is the sole awardee on this delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,701.55, is a Firm Fixed Price Delivery Order for the supply of Teriparatide 620 MCG/2.48 ML 2.48ML, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $4,839.84, is for the delivery of Teriparatide 620 mcg/2.48 ml medication in support of military treatment facilities and federal healthcare programs. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,920,473 units of teriparatide 620 mcg/2.48 ml medication. This $4,071.76 award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support Department of Defense military treatment programs and...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,330.16, is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has a completion date of January 9, 2025 and is a Firm Fixed Price (FFP) contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,591.28 firm fixed-price delivery order is for the supply of 4,566,328,918 units of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of November 5, 2024 and does not utilize any set-aside designation. AmerisourceBergen Drug...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,304.26 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564564429 - TERIPARATIDE 620 MCG/2.48 ML 2.48ML. This is not a set-aside contract. Amerisourcebergen Drug Corp's Corporate Office Division holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $2,591.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. The contract is a firm fixed-price delivery order that was awarded without the use of a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...